Your browser does not support JavaScript!

Targeted therapies are used in patients with a set gene expression pattern. A targeted therapy that prevents the activation of the estrogen receptor in breast cancer would be beneficial to which type of patient?

  • Patients who express the EGFR receptor in normal cells
  • Patients that have no estrogen receptor expressed in their tumor
  • Patients with a mutation that inactivates the estrogen receptor
  • Patients with lots of the estrogen receptor expressed in their tumor Correct
Similar BIO-6202 questions